Market research
300194.SHE Fuan Pharmaceutical (Group) Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5B
- P/E ratio
- 78.6
- Analyst target
- Not available
- Dividend yield
- 1.7%
- Beta
- 0.23
Community
Investor discussion
1 comment
Sign in to join the 300194.SHE discussion.
5 years, 5 months ago
Fuan Pharmaceutical (Group) Co., Ltd is currently in a long term downtrend where the price is trading 9.1% below its 200 day moving average.
From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Fuan Pharmaceutical (Group) Co., Ltd's total revenue sank by 18.2% to $548M since the same quarter in the previous year.
Its net income has dropped by 79.4% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 215.5% to $-28M since the same quarter in the previous year.
Based on the above factors, Fuan Pharmaceutical (Group) Co., Ltd gets an overall score of 1/5.